Baixar PDF

Outros usuários também visualizaram estes artigos

Treatment with low-dose tyrosine kinase inhibitors due to significant haematologic toxicity in patients with CML with prolonged treatment failure prevents haematologic progression Lucia Vráblová; Hana Klamová; Ivana Skoumalová; Jana Navrátilová; Romana Janská; Jan Grohmann; Milena Holzerová; Edgar Faber;
Hematol Transfus Cell Ther. 2024;46 Supl 6:S171-81
An interesting case of chronic myeloid leukemia with twists and turns Thulasi Raman Ramalingam; J. Subramanian; I. Nagarathinam; C. Chandran; L. Vaidhyanathan; J.M. Easow;
Hematol Transfus Cell Ther. 2024;46 Supl 6:S385-8
Myeloproliferative Neoplasm Symptom Assessment Form - Total Symptom Score (MPN-SAF TSS) questionnaire: translation, cultural adaptation and validation to Brazilian Portuguese Mariana Guaraná; Andréa Soares; Adelmo Daumas; Irene Biasoli; Cristiana Solza;
Hematol Transfus Cell Ther. 2022;44:321-7